OLMA — Olema Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $614.23m
- $156.16m
Brief: Olema Oncology Q3 Net Income USD -21.502 Million
Olema Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results For Palazestrant
Brief: Olema Oncology Kat6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
U.S. STOCKS ON THE MOVE-Hyatt Hotels, Walmart, Maxeon
U.S. STOCKS ON THE MOVE-Olema Pharma, Akamai Technologies, US banks
Olema Pharma up on expanded partnership with Novartis
Brief: Olema Oncology Announces Expansion Of Collaboration Agreement With Novartis
U.S. RESEARCH ROUNDUP-Arm Holdings, Expensify, New Relic
Olema Pharma hits highest in 1-1/2 years after private placement
Brief: Olema Oncology Announces Combined Financing For Up To $180 Mln
Olema Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Olema Pharmaceuticals Inc expected to post a loss of 73 cents a share - Earnings Preview
Olema Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Olema Oncology Reports First Quarter 2023 Financial Results And Provides Corporate Update
Olema Pharmaceuticals Inc expected to post a loss of 65 cents a share - Earnings Preview
Brief: Olema Pharmaceuticals Inc - Confirms That It Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
Brief: Olema Pharmaceuticals Inc Files For Common Stock Offering Of Up To $100 Million - SEC Filing
Olema Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary